Testing effectiveness (Phase 2)Study completedNCT02844439
What this trial is testing
Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Who this might be right for
GlioblastomaRecurrent GlioblastomaBrain Tumor
Kadmon Corporation, LLC 40